[PTGX] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -0.83%
YoY- -81.04%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue -8,189 1,560 2,353 6,117 11,674 10,781 11,282 -
PBT -30,803 -13,920 -14,664 -8,735 -8,663 -7,661 -3,052 369.00%
Tax -1,629 183 -799 0 0 0 -117 481.54%
NP -29,174 -14,103 -13,865 -8,735 -8,663 -7,661 -3,052 352.27%
Tax Rate - - - - - - - -
Total Cost 20,985 15,663 16,218 14,852 20,337 18,442 14,334 29.02%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 356.26 -904.04 -589.25 -142.80 -74.21 -71.06 -27.05 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -1.18 -0.58 -0.57 -0.38 -0.41 -0.36 -0.15 297.04%
EPS Diluted -1.18 -0.58 -0.57 -0.38 -0.41 -0.36 -0.15 297.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.